Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole transcriptome analysis of osteoclasts after treatment with or without etelcalcetide

ABSTRACT: Whole transcriptome analysis of osteoclasts after treatment with or without etelcalcetide

PROVIDER: PRJNA1020088 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26150810_1.fastq.gz	Fastqsanger.gz
	SRR26150810_2.fastq.gz	Fastqsanger.gz
	SRR26150811_1.fastq.gz	Fastqsanger.gz
	SRR26150811_2.fastq.gz	Fastqsanger.gz
	SRR26150812_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Whole transcriptome analysis of osteoclasts after treatment with or without etelcalcetide

Project description:Phosphate binders, vitamin D analogs, and calcimimetics have recently been used to control the disturbed mineral metabolism in chronic kidney disease-mineral and bone disorder (CKD-MBD). Etelcalcetide , a new calcimimetic agent approved by is considered by patients due to its convenience as an intravenous form which easily affordable during dialysis sessions. In this study, we evaluated the effects of etelcalcetide on osteoclasts.

2024-10-10 | GSE243811 | GEO

Whole transcriptome analysis of murine endothelial cells after treatment with or without nattokinase

Project description:Whole transcriptome analysis of murine endothelial cells after treatment with or without nattokinase

| PRJNA1013186 | ENA

Whole transcriptome analysis of human kidney cells after treatment with or without phosphoramidon

Project description:Whole transcriptome analysis of human kidney cells after treatment with or without phosphoramidon

| PRJNA839257 | ENA

Expression profile of osteoclasts treated with bisphosphonates

Project description:Bisphosphonates are the mainstay of therapy worldwide for osteoporosis. They inhibit the activities of the osteoclasts, the bone resorption cells. While bisphosphonates are known to block farnesyl pyrophsophate synthase to exert their anti-resorptive action, the detailed mechanism is not well understood. Examining the change in expression profile before and after bisphosphonate treatment in the osteoclasts might shed some light on the biological pathways that are perturbed. Osteoclastic precursor cells were treated with (or without) bisphosphonates (alendronate or risedronate) during their differentiation into mature osteoclasts.

2014-11-06 | E-GEOD-63009 | biostudies-arrayexpress

Whole transcriptome analysis of mouse liver tissues after treatment with or without polystyrene microplastics

Project description:Whole transcriptome analysis of mouse liver tissues after treatment with or without polystyrene microplastics

| PRJNA1164147 | ENA

Comprehensive transcriptome analysis of osteoclasts with the SIK3 deletion and pterosin B treatment.

Project description:Maintenance of bone homeostasis and the balance between bone resorption and formation are crucial for maintaining skeletal integrity. Osteoclasts are responsible for bone resorption and play a vital role in this process. The role of salt-inducible kinase 3 (SIK3) in osteoclast differentiation and maturation and its potential as a therapeutic target for osteoporosis remain poorly understood. Here, we generated osteoclast-specific Sik3 conditional knockout (cKO) mice and investigated the effects of SIK3 deletion on bone homeostasis. Our findings revealed increased bone mineral density and an osteopetrosis phenotype in Sik3 cKO mice, indicating the involvement of SIK3 in bone resorption. Furthermore, we examined the effect of pterosin B, an SIK3 inhibitor, on osteoclast differentiation. Pterosin B treatment inhibits osteoclast differentiation in vitro, reduces the number of multinucleated osteoclasts, and suppresses bone resorption. Therefore, in this study, to better understand the molecular mechanism of SIK3 in osteoclast differentiation and maturation, we performed gene expression profiling of bone marrow monocytes from SIK3 deletion and pterosin B treated mice using RNA sequencing (RNA-seq).

2024-07-21 | GSE234221 | GEO

Comprehensive transcriptome analysis of osteoclasts with the SIK3 deletion and pterosin B treatment.

Project description:Comprehensive transcriptome analysis of osteoclasts with the SIK3 deletion and pterosin B treatment.

| PRJNA980570 | ENA

Effect of BMS-582949 treatment on gene expression in osteoclasts

Project description:Effect of BMS-582949 treatment on gene expression in osteoclasts

| PRJNA1051041 | ENA

Transcription profiling of mouse ERa abalated differentiated osteoclasts

Project description:Estrogen clearly prevents osteoporotic bone loss by attenuating bone resorption. The molecular basis of how this is accomplished, however, remains elusive. Here we report a critical role of osteoclastic ERa in mediating estrogen action on bone in females. We selectively ablated ERa in differentiated osteoclasts (ERa dOc/dOc). ERa dOc/dOc females, but not males, exhibited clear trabecular bone loss, similar to the osteoporotic bone phenotype in post-menopausal women. Recovery of bone loss by estrogen treatment of the ovariectomized ERa dOc/dOc females was ineffective in the trabecular areas of the long bones and lumbar vertebral bodies. Osteoclastic apoptosis, induced by estrogen, occurred simultaneously with up-regulation of Fas ligand (FasL) expression in intact trabecular bones of ERa +/+mice, but not in ERa dOc/dOc mice. ERa was also required for similar effects of estrogen and tamoxifen in cultured osteoclasts. These findings suggest that the osteoprotective actions of estrogen and SERMS are mediated at least in part through osteoclastic ERa in trabecular bone; and the life span of mature osteoclasts is regulated through activation of the Fas/FasL system. Experiment Overall Design: Wild type and osteoclast-specific Estrogen Receptor alpha knock-out mice were ovariectomized. The number of both genotypes of mice was eight. The mice of each genotypes were divided to vehicle control and estrogen treated group. Four hours after chemical treatment, the distal 5 mm of the left femurs were harvested after sacrificing by cervical dislocation and total RNAs were purified for Affymetix GeneChip microarray analysis without pooling. Therefore, this experiment consists of four groups with four replicates per group.

2008-06-15 | E-GEOD-7798 | biostudies-arrayexpress

Whole transcriptome analysis of mouse maturation ameloblasts with or without WDR72

Project description:Whole transcriptome analysis of mouse maturation ameloblasts with or without WDR72

| PRJNA794140 | ENA